Status:
UNKNOWN
Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis
Lead Sponsor:
International Geriatric Radiotherapy Group
Collaborating Sponsors:
Brigitta G. Baumert
Conditions:
COVID-19 Pneumonitis
Eligibility:
All Genders
65+ years
Phase:
PHASE1
PHASE2
Brief Summary
Low dose whole lung radiotherapy may improve survival of older patients with COVID-19 pneumonitis
Detailed Description
Background: Coronavirus disease 19 (COVID-19) carry a high mortality rate among older patients and minorities such as ethnic Africans and Latinos. The chronic baseline systemic inflammation of older p...
Eligibility Criteria
Inclusion
- 65 years-old or older patients with proven COVID-19 pneumonitis who may or may not require oxygen
Exclusion
- Patients with pneumonia who do not have a diagnosis of COVID-19 infection, patients with COVID-19 pneumonitis who require artificial ventilation or hemodynamically unstable to undergo radiotherapy or consent cannot be obtained either through the patient or power of attorney or patients already enrolled in another clinical trial
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04493294
Start Date
November 1 2020
End Date
December 1 2021
Last Update
July 30 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.